{"id":45051,"date":"2022-06-14T14:02:08","date_gmt":"2022-06-14T12:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-uv-installs-patented-lumicide-surface-disinfection-solution-into-nycs-mt-sinai-medical-center-morningside\/"},"modified":"2022-06-14T14:02:08","modified_gmt":"2022-06-14T12:02:08","slug":"applied-uv-installs-patented-lumicide-surface-disinfection-solution-into-nycs-mt-sinai-medical-center-morningside","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-uv-installs-patented-lumicide-surface-disinfection-solution-into-nycs-mt-sinai-medical-center-morningside\/","title":{"rendered":"Applied UV Installs Patented LumiCide Surface Disinfection Solution into NYC\u2019s Mt. Sinai Medical Center Morningside"},"content":{"rendered":"
\n

\nOne of The World\u2019s Prestigious Hospitals<\/b>\n<\/p>\n

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc.<\/a> (NasdaqCM: AUVI<\/a>) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (\u201cUVC\u201d) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announces that its wholly owned subsidiary SteriLumen has just installed its patented LumiCide Surface and Drain UVC Disinfecting Systems<\/a> initially, in 17 patient rooms within the world renowned Mt. Sinai Medical Center Morningside. Mount Sinai Morningside<\/a>, formerly known as Mount Sinai St. Luke’s, is a teaching hospital located in the Morningside Heights neighborhood of Manhattan in New York City.\n<\/p>\n

\nMt. Sinai plans to publish the results in an Academic Paper later this summer which would further validate the previously obtained independent results conducted by ResInnova Laboratories. This validation could facilitate the adoption of our LumiCide Surface and Drain disinfection solutions throughout healthcare facilities globally.\n<\/p>\n

\nMount Sinai Morningside is affiliated with the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System, a nonprofit hospital system formed by the merger of Continuum Health Partners and the Mount Sinai Medical Center in September 2013. It provides general medical and surgical facilities, ambulatory care, and a Level 2 Trauma Center, verified by the American College of Surgeons. It operates 21 clinics and as of 2020, is nationally ranked by U.S. News & World Report<\/a>.\n<\/p>\n

\nJohn F. Andrews Applied UV\u2019s CEO and Director stated, \u201cWe welcome Mt. Sinai Medical Center to the Applied UV Family. The addition of this premier, globally recognized, and respected teaching institution to our growing list of leading hospitals who place their trust in our patented disinfection products (both air and surface) is further testament to the proven effectiveness but also, too the growing interest of globally recognized brands and companies who use our family of solutions to protect their facilities, employees, and products from harmful airborne and surface related pathogens. We look forward to a long and successful relationship with the Mt. Sinai team.\u201d\n<\/p>\n

\nThe LumiCide Disinfection System product line has the following attributes:\n<\/p>\n